Patents Assigned to NEWTHERA
  • NOVEL USES FOR DRUGS TARGETING GLUTAMINE SYNTHETASE
    Publication number: 20090209474
    Abstract: The present invention relates to novel therapeutic uses of tianeptine, salts, isomers, pro-drugs, metabolites and structural analogs thereof. Furthermore, the present invention relates to the use of tianeptine, salts, isomers, pro-drugs, metabolites and structural analogs thereof, in obtaining methods of screening and of developing drugs. Finally, the present invention relates to the novel therapeutic use of other glutamine synthetase (GS) ligands and to the use of these ligands in obtaining methods for screening and developing drugs.
    Type: Application
    Filed: August 8, 2006
    Publication date: August 20, 2009
    Applicant: NEWTHERA
    Inventors: Jean-Christophe Roegel, Pierre Eftekhari